Safety of Adenosine for Acute Pulmonary Vasoreactivity Testing in Pulmonary Hypertension

Journal Title: Multidisciplinary Cardiovascular Annals - Year 2016, Vol 7, Issue 1

Abstract

Background Acute pulmonary vasoreactivity testing (APVT) is performed during right heart catheterization (RHC) in patients with pulmonary arterial hypertension (PAH) to identify those who may benefit from long-term calcium channel blocker (CCB) therapy. Inhaled nitric oxide (iNO) is the most commonly used agent. However, a few other agents such as intravenous (i.v.) epoprostenol or i.v. adenosine can also be used. At present, intravenous prostaglandins and iNO are expensive and not-easily available in most Iranian medical facilities. Indeed intravenous adenosine is less expensive and available in all hospital settings. Objectives We aimed to investigate the safety profile of adenosine in a group of Iranian PAH patients undergoing APVT. Methods In this prospective study, a total of 57 consecutive patients with PAH who were scheduled to undergo RHC were enrolled. Acute reactivity testing was performed in 56 patients. Results Twenty (36%) patients had positive APVT. In all cases, adenosine administration was limited by the occurrence of drug-induced minor side effects including chest pressure or tightness, flushing and dyspnea. The maximal tolerated dose of adenosine was 225 ± 25 µg/kh/min (range 200 - 300 µg/kh/min) in the study population. Only 2 patients developed atrioventricular block at doses of 100 µg/kh/min and 150 µg/kh/min, respectively. Both patients spontaneously converted to sinus rhythm within one minute of discontinuation of adenosine infusion. Conclusions Intravenous adenosine can be safely used for APVT in Iran.

Authors and Affiliations

Ahmad Amin, Hossein Navid, Mitra Chitsazan, Bahar Ghaleshi, Sepideh Taghavi, Nasim Naderi

Keywords

Related Articles

The Role of Anterior Translocation of Right Pulmonary Artery in the Correction of Aortic Arch Anomalies from the Midline

Introduction Dilated pulmonary artery can increase the postoperative airway complications after the simultaneous repair of aortic arch anomalies and cardiovascular lesions with la...

Radiation Dose in Diagnostic and Therapeutic Procedures of Congenital Heart Diseases in Children

Background There is concern about radiation dose in children during cardiovascular catheterization and many believe that the use of computerized tomography is much better than con...

The Frequency of Dysphagia after Intraoperative Transesophageal Echocardiography in Open Cardiac Surgery

Objectives The current study tries to assess the causative factors of dysphagia and omit them to find the exact contribution of TEE for this symptom among patients who suffer from...

A Case of Beating Heart High Risk Aortic Valve Replacement in the Setting of Previous Bypass Graft Surgery

Background Conventional aortic valve replacement (AVR) surgery has been performed using cardioplegic cardio-respiratory arrest method. However this technique is often challenged w...

Cryoablative Cox Maze Procedure and Pulmonary Vein Isolation for Treatment of Atrial Fibrillation in Rheumatic Heart Disease Undergoing Mitral Valve Surgery

Introduction The cox-maze procedure (CMP) is considered the gold standard surgical therapy for atrial fibrillation (AF), however, cryosurgical ablations are changing daily practic...

Download PDF file
  • EP ID EP229223
  • DOI 10.17795/mcardia.9324
  • Views 95
  • Downloads 0

How To Cite

Ahmad Amin, Hossein Navid, Mitra Chitsazan, Bahar Ghaleshi, Sepideh Taghavi, Nasim Naderi (2016). Safety of Adenosine for Acute Pulmonary Vasoreactivity Testing in Pulmonary Hypertension. Multidisciplinary Cardiovascular Annals, 7(1), -. https://www.europub.co.uk/articles/-A-229223